is the linkage between the ␣-anomeric carbon atom in lar IgA1 in IgA nephropathy.
These results indicate that the decreased sialylation and galactosylation of the IgA1 hinge glycopeptides play a crucial role O-glycan sites at Thr 225 and Thr 236 were partially occupied in its glomerular deposition in IgAN. in the hinge peptide (Fig. 1B) [3]. There have been several reports analyzing the structural varieties of O-glycans in the hinge region of serum The human IgA1 molecule, which is known to be preIgA1 in . Mestecky et al [6] , Allen, Harper, dominantly deposited in glomeruli in IgA nephropathy and Feehally [7] , and Tomana et al [8] found the in-(IgAN) [1] , is one of the few serum glycoproteins because creased binding of GalNAc-specific lectins to serum it possesses O-linked oligosaccharide (O-glycan) side IgA1 in IgAN, suggesting the undergalactosylation of chains in its hinge region [2, 3] . The majority of serum the IgA1 hinge glycopeptides. However, the precise proteins are glycoproteins, and the sugar side chains structural definition of the defect has proved technically linking to proteins are usually N-linked oligosaccharides difficult and remains unconfirmed. Recently, Allen et al (N-glycans). The fundamental structure of the O-glycans precisely analyzed the O-glycan structure of serum IgA1 using fluorophore-assisted carbohydrate electrophoresis (FACE) and demonstrated that the IgA1 O-glycan in the previous studies were obtained from serum because of the technical limits of the sensitivity. To the structure of O-glycans in the hinge region of the IgA1 using matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOFMS). From our previous study [11] , it was expected that analyses using 1997 were the subjects of this study. Informed consent MALDI-TOFMS make it possible to overcome the probhad been obtained from each patient when they underlem of analyzing such a small amount of IgA.
went the renal biopsy. The mean age at the time of the renal biopsy was 36. antihuman IgA column (3 mL) similar to the isolation The pooled specimens in PBS were then transferred of the glomerular IgA. to a 100 mesh stainless steel sieve (pore size 140 ). The tissue was forced through the sieve by moderate pressure Preparation of IgA1 hinge glycopeptides using the bottom of a metal spoon along with repeated These procedures were performed according to our washing with cold PBS (300 mL). The pressing was conprevious studies [11, 13] . tinued for about 10 minutes; the material remaining on
Preparation of S-pyridylethylated ␣ chain from sepathe screen was discarded. The sieved suspension was rated IgA. The isolated IgA samples were dissolved in then poured through a 60 mesh (pore size 230 ) sieve, 500 L of 0.4 mol/L Tris-HCl buffer, pH 8.6, containing which retained a few of the large fragments, and finally 6 mol/L guanidine-HCl and 0.2 mol/L ethylenediaminethrough a 250 mesh sieve (61 opening). The material tetraacetic acid (EDTA). To dissociate the disulfide linkretained on the fine sieve was then extensively washed age, dithiothreitol solution (200 mg/mL) was added and with 300 mL of cold PBS.
stirred (serum IgA, 5.0 L/IgA mg; deposited IgA, This material was washed into a beaker, transferred 10 L/sample). After heating at 50ЊC for four hours, to a 50 mL plastic centrifuge tube, and centrifuged at 1.6 L/IgA mg (deposited IgA, 10 L/sample) of 4-vinyl 120 ϫ g at 4ЊC for 10 minutes. A sample of the sediment pyridine was added, and the reaction mixture was alwas examined by phase-contrast microscopy, and the lowed to stand for 90 minutes at room temperature. The number of nonglomerular fragments per 100 glomeruli reaction was terminated by the addition of 50 L of was counted. The total number of isolated glomeruli was 2 mol/L formic acid, and the mixture was then dialyzed also calculated. It was found that 88% of the fragments overnight against distilled water at 4ЊC. were isolated glomeruli.
Preparation of IgA1 hinge glycopeptides from trypsin digest of IgA1 molecules. The dissociated and S-pyridylElution of IgA from isolated glomeruli ethylated IgA1 molecules were dissolved in 160 L of To elute the deposited IgA, the pellet of the isolated 50 mmol/L Tris-HCl buffer, pH 8.0, containing 2 mol/L glomeruli was suspended in 10 mL of PBS solution conurea. Twenty microliters of trypsin solution (10 g taining 6 mol/L urea and was incubated for 90 minutes trypsin/20 L of the previously mentioned buffer) and at 37ЊC with shaking. The solution was then gently centri-20 L of 0.1 mol/L CaCl 2 were added, and the reaction fuged (120 ϫ g for 10 min). The supernatant was dialyzed mixture was incubated overnight at 37ЊC. The trypsin against PBS overnight at 4ЊC. digest was made up to 2 mL by adding PBS, pH 7.4. The sample was applied to a Jacalin-agarose column (2 mL), Sample preparation of IgA and the passed fraction was eluted with 20 mL of the Isolation of eluted IgA from glomeruli. To perform previously mentioned buffer. After further washing the 50% ammonium sulfate precipitation, the dialyzed sucolumn with 20 mL of 0.8 mol/L glucose, the ␣1 hinge pernatant containing deposited IgA was mixed with an glycopeptide fraction was eluted with 6 mL of 0.1 mol/L equal volume of saturated ammonium sulfate. After melibiose in the buffer. In our previous study, it was dissolving the precipitate with 5 mL of PBS, the soluestablished by the Edman degradation method that the tion was applied to the anti-IgA antibody coupled actifollowing 33mer IgA1 fragments containing IgA1 hinge vated sepharose 4 B column (1 mL). After the column glycopeptides were isolated by these procedures [11] was thoroughly washed with PBS, IgA was eluted with HYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSPS, 2 mol/L urea. The solution was then applied on a PD where the italicized sequence indicates hinge peptide 10 (5 mL) column to delete the salts and lyophilized.
core. Purification of serum IgA. Approximately 5 mL of Purification of the glycopeptides by high-performance serum from each subject were also mixed with an equal liquid chromatography (HPLC) was carried out using volume of saturated ammonium sulfate, and the precipia Cosmosil 5C18-300 column (Nacalai Tesque, 4.6 ϫ tate obtained was dissolved, dialyzed against PBS, and 150 mm). Elution was carried out using a linear gradient applied to the Jacalin-agarose column (3 mL). After the for 60 minutes from 0 to 90% acetonitrile in 0.1% triflucolumn was thoroughly washed with PBS, it was first oracetic acid (TFA) with a 0.5 mL/min flow rate. Detection was performed by monitoring the ultraviolet absorpeluted with 0.8 mol/L glucose and then with 0.1 mol/L tion at 220 nm. Under these chromatographic conditions,
x GalNAc ϩ y Gal ϩ z NANA. In this formula, the the definite peak composed of the IgA1 hinge glycopepmolecular weights of each factor were as follows: 33mer tides was observed around 20 minutes in all the serum HP, 3475.7; GalNAc, 203.2, Gal, 162.2; and NANA, 291.3. samples (Fig. 2) . The material eluted at the peak position
The combination number of x, y, and z was determined of the hinge was collected and lyophilized. As expected, from the molecular weights. the content of the isolated hinge of glomerular IgA1 was Each peak in the mass spectrum was regarded as the so small that no definite peak was observed on the HPLC corresponding glycoform of the hinge, if the measured chromatogram. Therefore, the 19-to 21-minute fractions molecular weight of the peak was consistent with the were obtained and lyophilized in the same manner. theoretical molecular weight of the hinge structure within a 0.5% error.
MALDI-TOFMS analyses
To perform the further analyses, the largest five peaks The isolated hinge glycopeptides were analyzed by in each of the five IgA1 samples (total 25 peaks) were MALDI-TOFMS in the positive ion mode to suppress selected. Since eight peaks overlapped among the samthe production of the adduct ion. The mass spectrometer ples, 17 peaks were studied. The peaks are underlined used in this work was a Voyager-DE (PerSeptive Biosysin the Table 2 , and labeled alphabetically (a) to (e) in tems, Framingham, MA, USA). The matrix used was a asialo-type and (1) to (12) in sialo-type structure ( Table 2 ). The number of GalNAc, Gal, and NANA acid (DHB) and 5-methoxy salicylic acid in the ratio of of the 17 major peaks was compared among the glomeru-9:1 in 50% acetonitrile and 0.1% TFA/H 2 O. The condilar IgA (Glom. IgA) and serum IgA of IgAN (SN IgA) tions of the mass spectrometry were as follows: acceleratand that of the controls (SC IgA) using Mann-Whitney's ing voltage of 20,000 and grid voltage of 94.0%; 256 shots U-test. As both serum groups had two samples, the analywere then summed. sis numbers were 5 in Glom. IgA and 10 in the serum The calibration of m/z was performed using adrenogroups. corticoid hormone (ACTH; m/z, 3661) and bovine insulin It was regarded as statistically significant if the P value (5737).
was less than 0.05. Figure 3 shows the actual mass spectra of the IgA1 compared among the five samples. The molecular size hinge in the five samples. It was obvious that the distribu-(m/z) of each peak was estimated, and the structure of tion of the peaks of glomerular IgA and of the IgAN the carbohydrate side chains in the IgA1 hinge (number groups was shifted to a lower molecular weight range of x, y, and z in the formula shown later in this article) compared with that of the control groups. was determined by referring to the corresponding theoAll of the assigned peaks in each IgA group are listed retical molecular weights calculated from the numbers in Table 2 . Among the 17 major peaks that were the of GalNAc, Gal, or sialic acid (NANA) according to largest five peaks in any of the five IgA1 samples (underthe following formula: molecular weight ϭ 33mer IgA1 fragment containing the hinge peptide (33mer HP) ϩ lined in Table 2 ), it was noted that four of the five main Minus signs mean not determined. Molecular weight ϭ 33mer hinge peptide ϩ x GalNAc ϩ y Gal ϩ z NANA ϭ 3475.7 ϩ 203.2 x ϩ 162.2 y ϩ 291.3 z. The observed peaks in every group of IgA1 are listed. In the 17 major peaks underlined, note that four of the five main peaks (peaks a, b, d and e) are asialo-type in the glomerular IgA1 hinge glycopeptides.
Data analyses RESULTS

The distribution of the MALDI-TOFMS peaks was
(a-e): Assigned major peaks of asialo-type hinge in each group.
(1-12): Assigned major peaks of sialo-type hinge.
peaks (peak a, b, d, and e) were asialo-type (Z ϭ 0) in serum IgA1 in IgAN were fewer than those in serum the glomerular IgA1 hinge glycopeptides. Figure 4 shows IgA1 in the control group. a comparison of the number of GalNAc, Gal, and sialic Urea was used for isolating deposited IgA from gloacid residues of the major peaks among the three IgA meruli. Since the effect of the treatment on the glycoform groups. The number of GalNAc was significantly deof the glom. IgA1 hinge was considerable, the O-glycan creased in the SN IgA group (mean Ϯ SD; 3.8 Ϯ 0.4) glycoform was compared between urea-treated and noncompared with that of the SC IgA group (5.1 Ϯ 0.6, P Ͻ treated IgA1 hinge glycopeptides. There was no signifi-0.001). The Gal content of Glom. IgA (2.0 Ϯ 1.4) was cant difference between them (data not shown). significantly lower than that of SC IgA (3.4 Ϯ 0.5, P Ͻ 0.05). The most striking difference was found in sialic DISCUSSION acid, which was significantly decreased in Glom. IgA
IgA nephropathy is defined as mesangial proliferative (0.2 Ϯ 0.4) compared with those of both the SN (1.2 Ϯ glomerulonephritis with the deposition of IgA and C3 in 0.8, P Ͻ 0.05) and SC IgA groups (2.4 Ϯ 0.7, P Ͻ 0.005).
the mesangium [14] . Therefore, circulating IgA immune The number of SN IgA was also significantly smaller complexes are thought to be involved in the pathogenesis than that of SC IgA (P Ͻ 0.01). Overall, numbers of carbohydrates composing O-glycans in deposited and of IgAN [15] . However, since deposited IgA appears to be polyclonal, displaying no apparent antigen restriction, in the specific release of the Gal␤1,3GalNAc side chains from the IgA1 hinge by gas-phase hydrazinolysis [21] , we have suggested that physicochemical abnormalities of IgA might be ascribed to its glomerular deposition in and found an increase in the asialo-Gal␤1,3GalNAc residue in the patients with IgAN [16] . However, these metha nonimmunologic manner [16] [17] [18] [19] .
In this study, we present the first information of precise ods failed to find any free GalNAc residue. Therefore, we could not obtain any information about the content structure of O-glycans in the deposited IgA1 in the glomeruli of IgAN by MALDI-TOFMS analyses. In our of Gal, which was bound to the outer side of GalNAc.
Recently, a few reports have appeared in which this previous studies using an early MALDI-TOFMS model [11, 13, 20] , it was impossible to analyze the native IgA1 problem was overcome using physicochemical methods. Allen et al precisely analyzed the O-glycan structure of hinge region. Only the molecular weights of the IgA1 fragments treated by the exo-glycosidases (neuraminiserum IgA1 using FACE and demonstrated that the IgA1 O-glycans chains were truncated with increased dase, ␤-galactosidase, and N-acetyl galactosaminidase) could be estimated. In the present study, we could diterminal GalNAc in IgAN [10] . In our most recent study, Odani et al developed a method for the direct analysis rectly analyze the native IgA1 hinge using the newer MALDI-TOFMS apparatus, which had a enough capacof the IgA1 hinge using electrospray ionization/liquid chromatography/mass spectrometry (ESI/LC/MS) and ity for estimating the molecular weights of the native IgA1 hinge glycopeptides.
observed a decreased sialylation and galactosylation of the hinge glycopeptides of serum IgA1 in IgAN [22] . We could differentiate the structure of the IgA1 hinge glycopeptides in the patients with IgAN from those in However, the physicochemical techniques such as hydrazinolysis, FACE, or ESI/LC/MS were unable to anathe non-IgAN controls. The results supported the series of previous studies [6] [7] [8] [9] [10] [11] , indicating that the IgA1 hinge lyze the O-glycan structure of the deposited IgA1 in the glomeruli because of its small quantity. The MALDIof IgAN patients was underglycosylated. The information obtained in these previous studies had been rather TOFMS apparatus used in our current study, however, had enough sensitivity to obtain the information from indirect and limited. The majority of the data were obtained by the binding capacity of IgA1 to the lectins such a small IgA1 sample. According to the manufacturer's instructions, the apparatus is capable of estimating recognizing each carbohydrate part of O-glycans in the IgA1 hinge. In the biochemical analyses, we succeeded molecular weights from 50 fmol/L of a calibration sample
